| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4403204
[patent_doc_number] => 06238664
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Process for stabilizing proteins'
[patent_app_type] => 1
[patent_app_number] => 9/196090
[patent_app_country] => US
[patent_app_date] => 1998-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 3925
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/238/06238664.pdf
[firstpage_image] =>[orig_patent_app_number] => 196090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/196090 | Process for stabilizing proteins | Nov 18, 1998 | Issued |
Array
(
[id] => 4306841
[patent_doc_number] => 06252055
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Concentrated antibody preparation'
[patent_app_type] => 1
[patent_app_number] => 9/180485
[patent_app_country] => US
[patent_app_date] => 1998-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5521
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252055.pdf
[firstpage_image] =>[orig_patent_app_number] => 180485
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/180485 | Concentrated antibody preparation | Nov 11, 1998 | Issued |
Array
(
[id] => 5827943
[patent_doc_number] => 20020068061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'HEPARANASE ACTIVITY NEUTRALIZING ANTI-HEPARANASE MONOCLONAL ANTIBODY'
[patent_app_type] => new
[patent_app_number] => 09/186200
[patent_app_country] => US
[patent_app_date] => 1998-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7270
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068061.pdf
[firstpage_image] =>[orig_patent_app_number] => 09186200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/186200 | Heparanase activity neutralizing anti-heparanase monoclonal antibody | Nov 3, 1998 | Issued |
| 09/185151 | MODIFIED ANTIBODIES AND ANTIBODY FRAGMENTS WITH INCREASED DURATION OF ACTIVITY | Nov 2, 1998 | Abandoned |
Array
(
[id] => 4370176
[patent_doc_number] => 06274710
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Antibodies which specifically bind T Cell inducible factors (TIFs)'
[patent_app_type] => 1
[patent_app_number] => 9/178973
[patent_app_country] => US
[patent_app_date] => 1998-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8945
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274710.pdf
[firstpage_image] =>[orig_patent_app_number] => 178973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/178973 | Antibodies which specifically bind T Cell inducible factors (TIFs) | Oct 25, 1998 | Issued |
| 09/168949 | LAMININS AND USES THEREOF | Oct 8, 1998 | Abandoned |
| 09/167182 | METHODS AND COMPOSITIONS FOR DECREASING MITOCHONDRIAL OVERPRODUCTION OF REACTIVE OXYGEN SPECIES IN CELLS | Oct 5, 1998 | Abandoned |
Array
(
[id] => 4400187
[patent_doc_number] => 06270772
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Recombinant MHC molecules useful for manipulation of antigen-specific T-cells'
[patent_app_type] => 1
[patent_app_number] => 9/153586
[patent_app_country] => US
[patent_app_date] => 1998-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 23960
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270772.pdf
[firstpage_image] =>[orig_patent_app_number] => 153586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/153586 | Recombinant MHC molecules useful for manipulation of antigen-specific T-cells | Sep 14, 1998 | Issued |
Array
(
[id] => 3905509
[patent_doc_number] => 06001357
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Method of enhancing wound healing with anti-IL-5 antibody'
[patent_app_type] => 1
[patent_app_number] => 9/143467
[patent_app_country] => US
[patent_app_date] => 1998-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 12732
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001357.pdf
[firstpage_image] =>[orig_patent_app_number] => 143467
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/143467 | Method of enhancing wound healing with anti-IL-5 antibody | Aug 26, 1998 | Issued |
| 09/138675 | MELTRINS | Aug 23, 1998 | Abandoned |
Array
(
[id] => 4333306
[patent_doc_number] => 06333034
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Process for inhibiting complement activation via the alternative pathway'
[patent_app_type] => 1
[patent_app_number] => 9/138723
[patent_app_country] => US
[patent_app_date] => 1998-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 16389
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333034.pdf
[firstpage_image] =>[orig_patent_app_number] => 138723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/138723 | Process for inhibiting complement activation via the alternative pathway | Aug 23, 1998 | Issued |
Array
(
[id] => 4092139
[patent_doc_number] => 06133428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Gab1, a Grb2 binding protein, and compositions for making and methods of using the same'
[patent_app_type] => 1
[patent_app_number] => 9/138236
[patent_app_country] => US
[patent_app_date] => 1998-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20928
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133428.pdf
[firstpage_image] =>[orig_patent_app_number] => 138236
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/138236 | Gab1, a Grb2 binding protein, and compositions for making and methods of using the same | Aug 20, 1998 | Issued |
| 09/065078 | HUMAN EPITHELIAL ANTIGEN EP-CAM DERIVED PEPTIDES AND THEIR USE | Aug 12, 1998 | Abandoned |
Array
(
[id] => 4352949
[patent_doc_number] => 06174513
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Stabilization of peptides and proteins for radiopharmaceutical use'
[patent_app_type] => 1
[patent_app_number] => 9/126545
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3975
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174513.pdf
[firstpage_image] =>[orig_patent_app_number] => 126545
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126545 | Stabilization of peptides and proteins for radiopharmaceutical use | Jul 29, 1998 | Issued |
| 09/122449 | NOVEL SPLICE VARIANTS OF A CD39 LIKE PROTEINS OBTAINED FROM A CDNA LIBERTY OF FETAL LIVER SPLEEN | Jul 23, 1998 | Abandoned |
| 09/102909 | PROTEINS AND PEPTIDES DERIVED FROM PROTEIN ESM-1 AND THEIR USES IN THE TREATMENT AND DIAGNOSIS OF DISEASES LINKED TO LEUKOCYTE MIGRATION | Jun 22, 1998 | Abandoned |
Array
(
[id] => 1459882
[patent_doc_number] => 06391852
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases'
[patent_app_type] => B1
[patent_app_number] => 09/094964
[patent_app_country] => US
[patent_app_date] => 1998-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7947
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09094964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/094964 | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | Jun 11, 1998 | Issued |
Array
(
[id] => 4288194
[patent_doc_number] => 06235487
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Method of diagnosing Crohn\'s disease'
[patent_app_type] => 1
[patent_app_number] => 9/117061
[patent_app_country] => US
[patent_app_date] => 1998-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8149
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235487.pdf
[firstpage_image] =>[orig_patent_app_number] => 117061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/117061 | Method of diagnosing Crohn's disease | May 21, 1998 | Issued |
Array
(
[id] => 4221986
[patent_doc_number] => 06040426
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Human Th2 specific protein'
[patent_app_type] => 1
[patent_app_number] => 8/981825
[patent_app_country] => US
[patent_app_date] => 1998-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11170
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040426.pdf
[firstpage_image] =>[orig_patent_app_number] => 981825
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/981825 | Human Th2 specific protein | May 10, 1998 | Issued |
| 09/043680 | INHIBITORS OF INTEGRIN RECEPTORS AND THEIR THERAPEUTICAL USES | May 6, 1998 | Abandoned |